Article
SPP1 as a Prognostic and Immunotherapeutic Biomarker in Gliomas and Other Cancer Types: A Pan-Cancer Study
1 Feb 2025
Abstract excerpt
Background: Gliomas, including glioblastoma (GBM), present significant treatment challenges due to their poor prognosis and complex tumor microenvironment. This study investigates the role of Secreted Phosphoprotein 1 (SPP1) as a prognostic and immunotherapeutic biomarker in gliomas and other cancers through pan-cancer analysis. Methods: A comprehensive pan-cancer analysis was conducted using datasets from UCSC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
